GoKawiilCancer care startup Thyme Care raises $125M, valuation tops $2 billion
Thyme Care, a virtual navigation platform for cancer patients, closed a $125 million Series E round led by Morgan Health with Humana and CVS Health Ventures participating, doubling its valuation to over $2 billion in less than a year. The company is also creating a new parent entity, Thyme Companies, to launch additional businesses tackling gaps in cancer care delivery, access and payment, with co-founder Robin Shah as executive chairman.